On Friday, Bath & Body Works Inc. (NYSE:BBWI) received an updated stock rating from JPMorgan, moving from 'Underweight' to 'Neutral'. The firm also set a new price target for the company's shares at $53.00. This adjustment comes as the analyst anticipates a stabilization in the company's first-quarter top-line revenue, projecting flat growth which is notably above the market's expectation of a 2.3% decline. This forecast is also an improvement compared to the company's previous eight quarters, which saw a 3.4% revenue decline.
The analyst's outlook suggests an early inflection point for Bath & Body Works, potentially returning to growth in the second quarter, ahead of management's projected timeline for the second half of the year. The upgrade reflects a multi-year model that includes low single-digit baseline comparable sales, supported by low single-digit percentage growth in Body Care, with Candle and Sanitizers sales expected to remain flat.
Additionally, JPMorgan's analysis includes a projection for low-to-mid single-digit square footage growth for Bath & Body Works. This is coupled with an anticipated high-teens operating margin profile, which the analyst believes could translate into a low double-digit earnings per share (EPS) growth. The forecast is further bolstered by the expectation of significant annual free cash flow generation, estimated to be over $500 million, which could support share buybacks.
The more positive stance from JPMorgan reflects a shift in expectations for Bath & Body Works' financial performance. The analyst's comments indicate that the company's revenue trends are showing signs of stabilization, and there is potential for growth as early as the next quarter. This marks a potential turnaround for the retailer, which has faced a period of revenue declines over the past two years.
InvestingPro Insights
Bath & Body Works Inc. (NYSE:BBWI) appears to be capturing the attention of investors and analysts alike, with JPMorgan's recent upgrade to a 'Neutral' stance and a price target of $53.00. Complementing this perspective, InvestingPro data highlights the company's market capitalization at a robust $10.95 billion, alongside a Price/Earnings (P/E) ratio of 12.75, which is in line with the adjusted P/E for the last twelve months as of Q4 2023. This valuation is underpinned by a solid gross profit margin of 43.56%, demonstrating the company's ability to maintain profitability amidst market fluctuations.
Two notable InvestingPro Tips for Bath & Body Works include the company's track record of maintaining dividend payments for 52 consecutive years, which could be a reassuring sign for income-focused investors, and the fact that its liquid assets exceed short-term obligations, indicating a strong liquidity position. Additionally, the company has experienced a significant price uptick over the last six months, with a 67.44% total return, hinting at investor optimism regarding its future performance.
For those interested in a deeper dive into Bath & Body Works' financial health and future prospects, InvestingPro offers additional insights and metrics. Visit https://www.investing.com/pro/BBWI for more detailed analysis and consider using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. There are 6 more InvestingPro Tips available that could further inform your investment decisions regarding BBWI.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.